Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Taysha Gene Therapies Inc
(NQ:
TSHA
)
3.000
+0.070 (+2.39%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Taysha Gene Therapies Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts
November 15, 2024
Via
Benzinga
Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday
November 14, 2024
Via
Benzinga
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
November 14, 2024
Via
Benzinga
Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"
November 14, 2024
Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks.
Via
MarketBeat
Earnings Scheduled For November 13, 2024
November 13, 2024
Via
Benzinga
Preview: Taysha Gene Therapies's Earnings
November 12, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights
August 12, 2024
Via
Benzinga
Where Taysha Gene Therapies Stands With Analysts
July 23, 2024
Via
Benzinga
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
November 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 12, 2024
Via
Benzinga
Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings
November 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday
November 12, 2024
Via
Benzinga
The Analyst Landscape: 16 Takes On Taysha Gene Therapies
June 17, 2024
Via
Benzinga
Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views
May 28, 2024
Via
Benzinga
11 Analysts Assess Taysha Gene Therapies: What You Need To Know
April 30, 2024
Via
Benzinga
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
November 12, 2024
Via
Benzinga
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Misses Revenue for Q2 2024
August 12, 2024
TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?
June 26, 2024
Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 26, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Via
InvestorPlace
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 19, 2024
Via
Benzinga
S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings
June 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 18, 2024
Via
Benzinga
Crude Oil Rises 1%; DermTech Shares Plummet
June 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
What's Going On With Taysha Gene Therapies Stock Tuesday?
June 18, 2024
Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome.
Via
Benzinga
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 12, 2024
U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
April 10, 2024
U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 09, 2024
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.